Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 9 recruiting now later-stage tilt

Brain Injuries: later-stage trial registry

9 of 24 indexed Brain Injuries trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #686 of 28,707 conditions by registered trial count.

24 US clinical trials · 9 currently recruiting · #686 of 28,707 conditions by registered trial count

Brain Injuries: 24 US clinical trials tracked, 9 recruiting.

Brain Injuries is the subject of 24 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is BrainScope Company, running 2 of these trials.

Enrollment posture brief

Registry condition brain-injuries

OPEN 9 | RECR 38% | LATE 3 | EARLY 1 | RANK #686 | SPON 2

Nearest open-share peer: Acute-graft-versus-host Disease (38% recruiting · 8 trials)

Brain Injuries (this)38%Aplastic Anemia37.5%Behavior37.5%Allergic Rhinitis8.3%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Brain Injuries

Brain Injuries lists 9 open slots (38% of 24 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Brain Injuries on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Brain Injuries is recruiting below its size-band peers.

    9 of 24 indexed trials (37.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Brain Injuries trials is spread across many organizations.

    BrainScope Company accounts for 2 of 24 trials (8.3%). 22 distinct sponsors appear on at least one study for this condition label.

  3. Typical Brain Injuries enrolment sits around 100 participants.

    Median target enrolment is 100 among the 23 trials that report a genuine target (sentinel values excluded). 11 of those (47.8%) plan for fewer than 100 participants.

  4. Brain Injuries research is mostly interventional.

    17 interventional and 7 observational studies make up this index (70.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 32Phase 41

Open and recent trials

24 total, page 1 of 1

RECRUITING 2,592 participants

Screening Emotions in Adolescents at the Hospital for mTBI

University of California, Davis

NCT06370520

RECRUITING NA 350 participants

Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma

Emory University

NCT06932588

RECRUITING NA 160 participants

Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)

United States Naval Medical Center, San Diego

NCT06413173

RECRUITING NA 160 participants

Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions

University of Pittsburgh

NCT02592291

RECRUITING NA 134 participants

The HOME Study (Healthy Options Made Easy): Telehealth Nutrition Sessions for People Living With Brain Injury

University of Alabama, Tuscaloo

NCT05965947

RECRUITING NA 130 participants

The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms

The University of Texas Medical Branch, Galveston

NCT06607523

RECRUITING NA 90 participants

Animal Assisted Therapy After Pediatric Brain Injury: Mediators and Moderators of Treatment Response.

Children's Hospital Medical Center, Cincinnati

NCT05250180

RECRUITING NA 30 participants

Multimodal Monitoring of Cerebral Autoregulation After Pediatric Brain Injury

University of Texas Southwestern Medical Center

NCT04242602

RECRUITING 25 participants

Correlation Between Noninvasive Blood Vessel Functionality Parameters and Cerebral Hemodynamics in Neurocritical Care Patients

University of Louisville

NCT06511804

ACTIVE NOT RECRUITING 100 participants

Metacognition in Neurological Injury

University of Nebraska Lincoln

NCT03752697

COMPLETED Phase 3 1,195 participants

Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury

BHR Pharma

NCT01143064

COMPLETED 981 participants

Validation Of TBI Detection System For Head Injured Patients

BrainScope Company

NCT02367300

COMPLETED 421 participants

Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department

BrainScope Company

NCT02367274

COMPLETED 321 participants

Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients

Oculogica

NCT02776462

COMPLETED Phase 2 261 participants

Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC

Neuren Pharmaceuticals Limited

NCT01366820

COMPLETED NA 67 participants

Long-term Effects of Blueberry Supplementation on Brain Health in Older Adults

Brigham and Women's Hospital

NCT05764824

COMPLETED NA 64 participants

Cortical Contributions to Motor Sequence Learning

Emory University

NCT04138953

COMPLETED NA 54 participants

The Use of Implementation Intentions to Increase the Appointment Attendance of OEF/OIF Veterans

VA Connecticut Healthcare System

NCT01649934

COMPLETED NA 42 participants

Hypothermia to Treat Severe Brain Injury

National Institute of Neurological Disorders and Stroke (NINDS)

NCT00040339

COMPLETED NA 35 participants

Youth Soccer Header Study

University of Wisconsin, Madison

NCT04919707

COMPLETED Phase 4 33 participants

Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity

The University of Texas Health Science Center, Houston

NCT00178646

COMPLETED 32 participants

Out-of-hospital Cardiac Arrest (OHCA) Biomarkers

University of Florida

NCT03112486

COMPLETED NA 5 participants

Impact of Custom Assistive and Adaptive Technology in Rehabilitation

Madonna Rehabilitation Hospital

NCT03567239

COMPLETED Phase 3

Magnesium Sulfate For Brain Injury

University of Washington

NCT00004730

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 2
Phase 4 1

Named interventions

Most-linked intervention names on Brain Injuries records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

BrainScope Ahead 200 Device
2 trials
Lipid emulsion without progesterone Drug
1 trials
Controlled and matched powder Other
1 trials
Blueberry powder Dietary supplement
1 trials
NNZ-2566 Drug
1 trials
Botox Drug
1 trials
Contact Clinic Behavioral
1 trials
Implementation Intention Behavioral
1 trials

US sites by state

Facility locations filed on Brain Injuries trials. A trial with sites in several states counts in each.

Texas 7 trials
Pennsylvania 6 trials
Georgia 4 trials
California 4 trials
Wisconsin 3 trials
Missouri 3 trials
Michigan 3 trials
Connecticut 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Brain Injuries page

24 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Brain Injuries condition card totals 24 registered trials; most-linked intervention BrainScope Ahead 200; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.